Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash Flows From Operating Activities:
Net loss	$ (1,633,473)	$ (2,184,966)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability		(858)
Change in fair value of investment option liability		(1,707)
Loss on write-off of deferred offering costs	19,597
Stock-based compensation	88,673	193,848
Amortization of intangibles		42,182
Depreciation expense	37,240	38,842
Change in operating assets and liabilities:
Prepaid expenses and other current assets	(251,611)	(46,126)
Accounts payable, accrued expenses and other current liabilities	(417,390)	(301,281)
Due to related parties	(99,875)	(131,516)
Net cash used in operating activities	(2,256,839)	(2,391,582)
Cash Flows From Financing Activities:
Proceeds from sale of common stock and warrants, net of offering costs	1,204,793	4,373,870
Proceeds from the exercise of warrants		75,044
Proceeds from sale of common stock for cash pursuant to the ATM Agreement, net of offering costs	1,298,415
Net cash provided by financing activities	2,503,208	4,448,914
Effect of foreign exchange rate on changes on cash	(15,091)	(3,923)
Net increase in cash	231,278	2,053,409
Cash at beginning of period	4,677,491	2,241,026
Cash at end of period	4,908,769	4,294,435
Supplemental disclosure of cash flow transactions:
Cash paid for interest
Income taxes paid
Non-cash financing and investing activities:
Non-cash issuance of round-up shares		874
Non-cash issuance of RSA vested shares		146
Offering costs accrued not paid	68,143	129,403
Issuance of Placement Agent Warrants as offering costs	63,000
Deferred offering costs not paid	$ 2,788